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Chronic, long-term respiratory morbidity (CRM) is common in patients with a history 
of repaired congenital esophageal atresia, typically associated with tracheoesophageal 
fistula (EA/TEF). EA/TEF patients are at high risk of having aspiration, and retrospective 
studies have associated CRM with both recurrent aspiration and atopy. However, stud-
ies evaluating the association between CRM in this population and either aspiration or 
atopy have reported conflicting results. Furthermore, CRM in this population may be 
due to other related conditions as well, such as tracheomalacia and/or recurrent infec-
tions. Aspiration is difficult to confirm, short of lung biopsy. Moreover, even within the 
largest evidence base assessing the association between CRM and aspiration, which 
has evaluated the potential relationship between gastroesophageal reflux and asthma, 
findings are contradictory. Studies attempting to relate CRM to prior aspiration events 
may inadequately estimate the frequency and severity of previous aspiration episodes. 
There is convincing evidence documenting that chronic, massive aspiration in patients 
with repaired EA/TEF is associated with the development of bronchiectasis. While 
chronic aspiration is likely associated with other CRM in patients with repaired EA/TEF, 
this does not appear to have been confirmed by the data currently available. Prospective 
studies that systematically evaluate aspiration risk and allergic disease in patients with 
repaired EA/TEF and document subsequent CRM will be needed to clarify the causes 
of CRM in this population. Given the prevalence of CRM, patients with repaired EA/TEF 
should ideally receive regular follow-up by multidisciplinary teams with expertise in this 
condition, throughout both childhood and adulthood.
Keywords: esophageal atresia with or without tracheoesophageal fistula, respiratory aspiration, tracheoesophageal 
fistula, esophageal atresia, gastroesophageal reflux
iNTRODUCTiON
Repaired esophageal atresia, typically associated with congenital tracheoesophageal fistula (EA/
TEF), is commonly associated with long-term respiratory morbidity, including recurrent respiratory 
tract infection, chronic cough, persistently abnormal pulmonary function, and reported asthma 
(1, 2). There are many potential causes for respiratory complications in this population. Clinically 
significant tracheomalacia may occur in up to 78% of EA/TEF patients. In infants, tracheomalacia 
may lead to cyanotic spells (2). In children and adults, tracheomalacia may cause reduced airway 
clearance, leading to persistent bacterial bronchitis (3, 4). Patients with repaired EA/TEF have 
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multiple, and sometimes interrelated risk factors for aspiration. 
Aspiration can be due to esophageal dysmotility, which is present 
in up to 75–100% of EA/TEF patients (2) or esophageal stricture. 
Gastroesophageal reflux disease (GERD) can also cause lung 
disease due to aspiration of gastric contents, and 35–58% EA/TEF 
patients have been reported to experience GERD. Recurrent TEF 
may arise in about 9% of EA patients. Laryngeal clefts (particu-
larly types 1 and 2) and unilateral or bilateral vocal cord paresis 
or paralysis appears to be frequent in EA/TEF patients, and often 
leads to aspiration (5, 6). Vocal cord paresis or paralysis may 
be, in at least some cases related to EA/TEF corrective surgery 
(7). Thoracic large vessel malformations such as aberrant right 
subclavian artery also appear to be abnormally common in EA/
TEF patients, and may worsen tracheal and esophageal function, 
leading to dyspnea, dysphagia, and aspiration (8). Recent studies 
indicate that other esophageal diseases that impair esophageal 
function may also be commoner in patients with repaired 
EA/TEF, further increasing the risk of aspiration, including 
eosinophilic esophagitis, congenital esophageal stenosis, and 
heterotopic gastric mucosa in the esophagus (9, 10). Patients with 
repaired EA/TEF may also develop other respiratory conditions, 
such as atopy and asthma (2, 11); potentially due to altered gas-
trointestinal mucosal immunity, they may actually be at increased 
risk for these conditions. At present, the extent to which chronic 
respiratory morbidity (CRM) is due to aspiration early in life is 
unclear. This paper will attempt to summarize current knowledge 
of the degree to which aspiration is responsible for CRM in these 
patients.
ASPiRATiON
Aspiration may be defined as the “inhalation of oral, gastric con-
tents into lower respiratory tract.” Its effect depends on whether 
the aspirate originates in the pharynx or stomach, whether it is 
liquid or solid, its pH, the presence of bacteria, and, importantly, 
its volume and the chronicity of the aspiration. There is evidence 
that at least 50% healthy adults aspirate small volumes oropharyn-
geal secretions while asleep, but this is cleared by airway clearance 
including cough, and by the immune system, leaving no sequelae 
(12). Aspiration is a general term used to describe a spectrum 
of acute lung syndromes such as aspiration pneumonitis, aspira-
tion pneumonia, and foreign body aspiration, as well as chronic 
pathology including diffuse aspiration bronchiolitis, bronchiecta-
sis, organizing pneumonia, and bronchiolitis obliterans syndrome 
(12, 13). Aspiration pneumonitis (Mendelson’s syndrome) is due 
to regurgitation of gastric contents in the presence of reduced 
consciousness such as anesthesia, leading to acute lung injury 
and/or acute respiratory distress syndrome. The aspirated fluid is 
typically sterile, at least initially, unless the gastric pH had previ-
ously been iatrogenically elevated (12). Aspiration pneumonia 
is caused by the aspiration of infected oropharyngeal secretions 
in patients who are at risk for aspiration. It is typically a patchy 
bronchopneumonia that, classically, is in the dependent lobes. 
Aspiration may lead to necrotizing bronchopneumonia and lung 
abscess formation (13).
Several research groups have described the pathology and 
radiology of chronic aspiration. Mukhopadhyay and Katzenstein 
reported the lung biopsy findings in 59 adults with aspiration 
pneumonia due to aspiration of particulate matter. Their mean 
age was 57 years, and, of interest to EA/TEF patients 32% of the 
cases had esophageal disease or a hiatus hernia. All of the speci-
mens contained alveolar foreign material, including vegetable 
matter in 92% of cases, and giant cells were present. Eighty-eight 
cases had cryptogenic organizing pneumonia (bronchiolitis 
obliterans organizing pneumonia) with intraluminal fibroblast 
plugs in the small bronchioles and alveolar ducts, mainly associ-
ated with foreign body-type suppurative granulomas, and foci of 
bronchopneumonia. A few cases had interstitial foreign mate-
rial with fibrosis (14). Cardasis et al. reported 25 adult patients 
with occult aspiration. Their mean age was 62 years. Ninety-six 
percent had GERD, 32% had a hiatal hernia, and 40% had other 
esophageal diseases. Biopsies revealed poorly formed granulomas 
near the bronchioles with evidence of chronic inflammation, and 
foreign body giant cells and lipoid pneumonia was common. 
On computerized tomography (CT) imaging, bronchial wall 
thickening, centrilobular nodules, and tree-in-bud opacities were 
observed. These were evident mainly in the lower lungs. A few 
cases had ground glass opacity, interstitial lung disease, or trac-
tion bronchiectasis (15). Pereira-Silva described an older patient 
population, consisting of 13 patients with chronic microaspira-
tion. Their mean age was 71 years. Sixty-nine percent had GERD, 
46% had a hiatus hernia, and 23% had esophageal dysfunction. 
CT scanning demonstrated centrilobular nodules and focal areas 
of ground glass opacity in all of the patients, and in 85%, these 
findings were present in the dependent lung regions. Branching 
(tree-in-bud) opacities were common, and bronchiectasis was 
evident in 54% (16). It has been reported that on pulmonary func-
tion testing (PFT), patients with chronic aspiration commonly 
have restrictive defects and a low diffusing capacity for carbon 
monoxide (DLCO) (17).
Aspiration is believed to contribute to a number of chronic 
lung diseases. Bronchiectasis is believed to be caused by aspira-
tion in 4–18% of patients with non-CF bronchiectasis. El-Serag 
et al. studied 1,980 neurologically normal children with GERD 
and 7,920 controls. They reported that the odds ratio (OR) for 
bronchiectasis was 2.3 (p <  0.0001), and pneumonia was 2.3 
(p < 0.02), among children with GERD (18). By contrast, Piccione 
et al. reported that in 66 patients with bronchiectasis diagnosed 
in a specialized Aerodigestive Clinic, aspiration-associated bron-
chiectasis was strongly associated with severe neurologic impair-
ment. Bronchiectasis was also associated with parental report of 
GER, but not with the results of esophageal impedance studies or 
prior fundoplication (19). However, in this population with severe 
neurologic impairment, CRM may have been predominantly due 
to chronic aspiration of saliva (20), and the findings may be of 
less relevance to populations with aspiration predominantly due 
to other causes. In patients with bronchiolitis obliterans syndrome 
post-lung transplant, GERD appears to play an important role in 
worsening lung function, and lung function improves with fun-
doplication (21). In idiopathic pulmonary fibrosis, lung function is 
possibly worsened by GERD, particularly in scleroderma patients, 
who may also have esophageal dysfunction. In pulmonary fibrosis 
patients, there is some evidence that medical anti-reflux therapy 
may slow the decline in lung function (13).
3Kovesi Aspiration and Esophageal Atresia
Frontiers in Pediatrics | www.frontiersin.org April 2017 | Volume 5 | Article 62
CLiNiCAL FeATUReS OF ASPiRATiON
Clinically, the diagnosis of aspiration may be obvious in the case 
of massive or witnessed choking, but often is under-recognized 
when due to subclinical microaspiration and misattribution of 
chronic cough, wheeze, and/or dyspnea.
DiAGNOSiNG ASPiRATiON
Confirming whether aspiration is occurring remains medically 
challenging. Several tests are available, and they tend to have 
widely varying reported sensitivity and specificity.
The presence of aspiration is confirmed by lung biopsy show-
ing evidence of a foreign body or foreign body granulomas (vide 
supra), a bronchoscopy demonstrating particulate matter, or when 
particulate matter is found in the bronchoalveolar lavage (BAL) 
fluid. Lipid from aspirated food or drinks is ingested by alveolar 
macrophages, and the presence of lipid-laden macrophages in 
the BAL has been proposed as evidence of aspiration. The lat-
ter may also be quantified as the BAL lipid-laden macrophage 
index (LLMI). This requires evaluation of 100 macrophages in the 
BAL, each of which is scored from 0 (no lipid) to 4 (completely 
opacified). The total is summed and can potentially range from 
0 to 400. A value over 100 has been considered as evidence of 
GERD with aspiration. However, necrosis of alveolar lining 
cells as a result of severe pneumonia also releases lipid from cell 
membranes into the BAL. As a result, while the LLMI has “been 
associated with chronic aspiration” its reported sensitivity varies 
from 57 to 100%, and its specificity from 57 to 89% (21). Borrelli 
et al. observed that the LLMI was significantly higher in children 
with recurrent lung consolidation than in children with asthma 
(p < 0.05), and that the LLMI correlated with the number of reflux 
and non-acid reflux episodes, and number of episodes reaching 
the proximal esophagus (p < 0.01) on pH-multichannel intralu-
minal impedance testing. The LLMI also significantly correlated 
with the number BAL neutrophils (p < 0.01) (23). By contrast, 
Rosen et al. found that in 50 children with a mean age of 6 years, 
the LLMI was not associated with pH-impedance findings, endo-
scopic esophagitis, or clinical improvement following fundopli-
cation (24). While BAL pepsin or bile acids have been proposed 
as markers of aspiration, they require further study (21). Exhaled 
breath condensate (EBC) was investigated by Fitzpatrick et al. as 
part of a study of lansoprazole in 110 children with asthma. They 
found no association between EBC and esophageal pH probe 
results. Moreover, EBC acidity did not change with lansoprazole 
and the investigators concluded that EBC does not appear to be 
useful in the evaluation of the respiratory effects of GERD (25).
Bacterial culture of the BAL fluid may be a surprisingly useful 
marker of aspiration. Rosen et al. observed that in 46 children 
with chronic cough or wheezing, with a mean age 74 months, 26% 
had a positive BAL culture. Cultures grew mainly Streptococcus 
pneumoniae and Haemophilus influenza. The presence of a posi-
tive BAL culture was predicted by the amount of non-acid reflux 
or full-column GER on a pH-impedance study, but not a history 
of pneumonia in previous 6 months. The presence of bacteria in 
the BAL may also reflect the effectiveness of mucociliary clear-
ance of any aspirated material (26).
In the future, examination of the lower airway microbiome 
(ribosomal 16  s rRNA ecosystem) may be helpful. The lower 
airways of healthy people have been reported to have low levels 
of mainly oral bacteria such as Prevotella and Veillonella (27), but 
the microbiome of individuals with chronic aspiration has not 
been investigated to date.
DeTeRMiNiNG THe SOURCe OF 
ASPiRATiON
When there is convincing evidence of aspiration, determining its 
source may be difficult, and different tests may provide conflict-
ing results.
Swallowing dysfunction can be demonstrated by vide-
ofluoroscopic swallowing study or, less commonly, fiberoptic 
endoscopic evaluation. Weir et  al. reported that aspiration of 
thin liquids or post-swallow residue, seen on videofluoroscopic 
swallowing study, was associated with pneumonia in a broad 
group of pediatric patients (28). These types of studies have 
demonstrated that aspiration due to abnormal swallowing is 
common in EA/TEF patients (29, 30). Esophageal dysfunction 
can be diagnosed by an upper gastrointestinal (UGI) series 
or manometry. High-resolution manometry, demonstrating 
aperistalsis in EA/TEF patients, has been associated with CRM 
(29). Video manometry, particularly to evaluate a lack of coor-
dination between pharyngeal contraction and relaxation of the 
upper esophageal sphincter, may also be helpful (31). Recent 
studies suggesting that laryngeal clefts and vocal cord paresis 
or paralysis are common in patients with EA/TEF indicate 
that careful otolaryngologic evaluation of the upper airway 
should be performed in EA/TEF patients suspected as having 
aspiration (5, 7). As thoracic vascular malformations may also 
compromise esophageal function in EA/TEF patients, complete 
cardiac evaluation of thoracic vessels should also be considered 
(8). A recurrent or persistent TEF is most often diagnosed by 
UGI with pull-back study. Many tests are available to diagnose 
GERD, including UGI, endoscopy, scintigraphy, and imped-
ance/pH probe.
Borrelli et al. used pH-multichannel intraluminal impedance 
to study 21 children, with a mean age of 4.1 years. They found 
that 49% of events were non-acid, 74% reached the proximal 
esophagus, and 80% of the episodes were liquid. The number of 
reflux episodes, non-acid reflux episodes, and non-acid reflux 
episodes reaching proximal esophagus were all significantly 
higher in children with recurrent lung consolidations than in 
children with asthma (p < 0.01) (23). Condino et al. performed 
these studies in 24 children with asthma and GERD, with a mean 
age of 33 months. They reported that 51% of events were non-
acid. However, there was a low association with symptoms; for 
example, only 8% of events were associated with cough (32).
Ravelli et  al. performed nuclear scintigraphy studies in 51 
neurologically normal children with a median age of 6.5 years. 
GER to the upper 1/3 of the esophagus was detected in 27% of 
the patients. Delayed gastric emptying (over 90 min) was seen 
in 53%, and aspiration on a 20-h delayed scan was observed in 
49% of children. However, this investigation correlated poorly 
with other tests. The number of reflux episodes did not differ in 
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children with normal or abnormal pH studies. Seventy-five per-
cent of the children who had aspiration on the delayed scan had 
a normal pH study, and few of them had histologic esophagitis. 
Aspiration was associated with CRM, with aspiration seen in 62% 
of children with recurrent pneumonia and all the infants with 
apnea. They felt that the sensitivity of the delayed scan was limited 
by the relatively short half-life of the technetium (33).
GeRD AND ASTHMA
The largest repository of data regarding the association of aspira-
tion with CRM concerns the possible link between GERD and 
asthma, with over 1,600 studies published. The possible relation-
ship between GERD and asthma is potentially bidirectional, with 
asthma increasing the risk of GERD, and GERD increasing the 
severity of asthma. GERD may worsen asthma through a reflex 
mechanism, with stimulation of vagal nerves in the esophagus by 
acid, since some of these afferents end in same region of nucleus 
of the solitary tract where respiratory sensory nerves terminate 
(34), or through microaspiration, leading to bronchoconstriction 
and airway inflammation. Non-acid GER may be particularly 
harmful, as it would likely stimulate airway protective reflexes 
less. These relationships appear to be complex, with studies show-
ing differing effects of reflux on asthma outcomes. For example, 
in one study of adults with asthma, omeprazole had no effect 
on methacholine challenge but did reduce cough sensitivity to 
capsaicin challenge in the patients who had pH probe-evidence 
of reflux (35). By contrast, another study observed a correlation 
between the number of esophageal reflux episodes and airway 
reactivity as evaluated by methacholine challenge (36).
In a systemic review, Thakkar et al. found that the prevalence 
of asthma in children with GERD was 13 versus 7% in controls 
(37). A systemic review in adults noted that the prevalence of 
GERD, using the Montreal definition, in adults with asthma was 
58%, compared to 38% in controls, giving an OR for GERD in 
adults with asthma of 5.5, and the OR for asthma in patients with 
GERD was 2.7 (36).
Several studies have evaluated whether GERD is associated 
with indicators of asthma control. In adults with poor asthma 
control, abnormal distal or proximal esophageal pH was associ-
ated with oral steroid use, and proximal reflux was associated with 
worse quality of life, but neither was associated with FEV1, asthma 
control, or methacholine challenge (38). By contrast, Kwiecien 
et  al. noted that in 66 children with asthma with a mean age 
10 years, night asthma symptoms were associated with a longer 
time spent at night with an esophageal pH below 4 (39).
Multiple studies have examined whether treating reflux 
improves asthma outcomes, although the results are contradic-
tory. A study of esomeprazole in 828 adults with asthma and a 
positive GERD score resulted in very small, but statistically sig-
nificant improvements in FEV1 and quality of life, but not in peak 
flow, exacerbations, or symptoms (40). In another, study of 207 
adults with asthma and GERD symptoms, lansoprazole improved 
quality of life and reduced exacerbations needing prednisone, but 
had no effect on lung function or symptoms (41). In a Cochrane 
systematic review (mainly involving adults), anti-GERD therapy 
had no consistent effect on peak flows or symptoms (42). Reducing 
gastric acidity does not appear to be effective in children or adults 
with asthma and no GERD symptoms (38, 43).
It is important to recognize that proton pump inhibitors do not 
treat non-acid GER. Rothenberg and Cowles described a series of 
235 children with asthma on prednisone who underwent laparo-
scopic Nissen fundoplication. Ninety percent reduced or stopped 
their steroids, 90% of children with night symptoms improved, 
and in the 56 children who underwent PFTs, FEV1 improved 26% 
(44). However, this was a non-controlled, non-blinded study.
In summary, anti-GER therapy appears to improve asthma 
to some extent in patients with asthma and symptomatic GERD, 
although the outcomes which improved vary between studies. 
Some of the variation may be related to differences in how GERD 
was defined. It is unclear why a treatment effect was seen only in 
patients with symptomatic GERD.
ASSOCiATiONS wiTH ReSPiRATORY 
MORBiDiTY iN PATieNTS wiTH RePAiReD 
eA/TeF
Recurrent infection, aspiration, and atopic disease have been 
associated with CRM in EA/TEF patients. In 68 patients with 
type C EA/TEF, respiratory complications including recurrent 
pneumonia were associated with GERD in 74% of patients, with 
recurrent TEF in 13%, and with esophageal strictures in 10% 
(45). Recurrent TEF has been associated with cough and with 
recurrent pneumonia (46). Bronchitis and pneumonia have been 
associated with dysphagia in 20 children with repaired EA/TEF 
(47). Shah et al. recently observed that early esophageal stricture 
formation was associated with recurrent pulmonary infections. 
GERD was associated with the subsequent performance of an 
aortopexy to treat severe tracheomalacia (9). A variety of studies 
have observed that PFT obstructive defects are associated with 
history of reported GERD (but not results of a 2-h pH probe), as 
well as choking spells during infancy, and pneumonia during the 
first 4 years of life (48–50).
Several studies have specifically examined the relationship 
between GERD and CRM in patients with repaired EA/TEF. 
However, several of these studies were likely limited by variability 
in the objective assessment of GERD. In addition, research to 
date has been retrospective and may underestimate GERD early 
in life. Peetsold et al. examined the effect of anti-GERD surgery 
as a marker of past, chronic GERD (51). They reported that 
neither exercise capacity nor PFT restrictive defects were associ-
ated with anti-GERD surgery, but prior surgery was associated 
with a lower FEV1. Using prior anti-GERD surgery as a marker 
of chronic GERD may be problematic. Anti-GERD surgery is 
clearly performed because of ongoing, incompletely controlled 
GERD. However, surgery may prevent GERD from leading to 
CRM. Furthermore, depending on the degree to which esopha-
geal function is impaired, fundoplication may actually worsen 
aspiration by causing retention of swallowed material in the 
esophagus, and oropharyngeal aspiration. Malmström found that 
in 23 adolescent EA/TEF patients, while 78% had a positive his-
tamine challenge (used as a marker of airway reactivity), airway 
reactivity was not associated with esophageal symptoms, prior 
fundoplication, the number of previous reported pneumonias, 
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the results of allergy testing, or physician diagnosis of asthma. 
Furthermore, airway reticular basement membrane thickening 
was not associated with gastrointestinal symptoms, esophageal 
biopsies, atopy, histamine challenge, or exhaled nitric oxide. In 
addition, PFT restrictive changes were not associated with cur-
rent esophageal symptoms or past fundoplication (52). Similarly, 
Legrand et al. found that PFT abnormalities among 57 children 
with repaired EA/TEF were not associated with GERD symptoms 
or the results of objective testing, or with prior fundoplication 
(53). A small study of 26 7-year olds with repaired EA/TEF had 
similar results, with no association between “esophageal symp-
toms” and PFT abnormalities, including lung clearance index (as 
a measure of small airway function). Furthermore, the results of 
24-h pH probe were not associated with respiratory symptoms. 
Olbers et al. also noted that PFT abnormalities in this population 
could be due to tracheomalacia (54). Pedersen et al. did not find 
a significant association between abnormalities of esophageal 
function (determined by endoscopy and pH probe) or a history 
of recurrent pneumonia, and either obstructive or restrictive PFT 
defects (55). Sistonen et  al. performed histamine challenges in 
101 adult patients with repaired EA/TEF. Forty-one percent were 
positive, and, as expected in individuals with asthma, a positive 
challenge was associated with atopy or an elevated serum IgE. 
Unexpectedly, an elevated exhaled nitric oxide was not associ-
ated with atopy. While a positive histamine challenge was not 
associated with esophageal metaplasia on esophageal biopsy, PFT 
restrictive defects were (56).
Atopic disease, including asthma, may be commoner in EA/
TEF patients than in the general population. It is conceivable that 
chronic aspiration and/or recurrent lower respiratory infection 
early in life results in persistent airway inflammation and a risk 
of asthma and other airway diseases later on. In addition to the 
effects of chronic aspiration, it is possible that altered mucosal 
immunity in the gastrointestinal tract changes cellular immunity 
and increases the risk of atopy. Whether asthma in EA/TEF 
patients is secondary to the effects of aspiration or primary, 
asthma may cause chronic respiratory symptoms in older patients 
with EA/TEF. In 334 adult EA/TEF patients, persistent respira-
tory symptoms were associated with allergies or a family history 
of allergy (50). In children with EA/TEF and wheezing, 2/3 had 
a history of atopy (47). Allergies appear to be common in EA/
TEF patients. Malmström et  al. reported that 15% of children 
with repaired EA/TEF had allergic rhinitis, and 54% had posi-
tive allergy skin tests (52). In adults with repaired EA/TEF, 42% 
had allergies, 37% had positive allergy tests, and 20% had a high 
serum IgE. Moreover, these findings were associated with current 
respiratory symptoms (56). Another smaller study of 28 adults 
with repaired EA/TEF found that increased airway reactivity, 
measured using methacholine challenge, was associated with 
serologic evidence of allergies and with elevated exhaled nitric 
oxide [generally an indicator of allergic airway inflammation (57)]. 
However, all of these tests were poorly associated with reported 
physician-diagnosed asthma (58). By contrast, while Robertson 
et al. found that methacholine challenge was positive in 48% of 
18 EA/TEF patients, it was not associated with symptoms of atopy 
(59). Similarly, Pedersen et  al. did not find that the frequency 
of allergies (measured by skin prick testing and by serum IgE), 
abnormal airway reactivity (measured by a mannitol challenge 
test), or abnormal exhaled nitric oxide differed between EA/TEF 
patients and a control group being evaluated for GERD (55).
Bronchiectasis is a potentially devastating long-term compli-
cation of EA/TEF (22). Using CT scanning, rates of bronchiec-
tasis in EA/TEF survivors may be as high as 27% (4, 55). While 
neither DeBoer et  al. (4) nor Cartabuke et  al. (60) examined 
potential associations with bronchiectasis (59), bronchiectasis 
in this population has generally been associated with massive 
aspiration, including patients with gastric or colonic interposi-
tion in a selected referral population (22), longstanding GERD 
(61), massive TEF pouch secretions, trisomy 21 (62), undiagnosed 
TEF (63), or broncho-esophageal fistula (64, 65).
SUMMARY
In the general population, bronchiectasis has been clearly associ-
ated with GERD and cryptogenic organizing pneumonia can 
result from chronic aspiration. The relationship between GERD 
and asthma is unclear, with various studies reporting conflict-
ing asthma morbidities associated with GERD. In patients with 
repaired EA/TEF, GERD has been inconsistently associated with 
a low FEV1 and with PFT restrictive defects. Early studies have 
suggested that aspiration early in life in EA/TEF patients is asso-
ciated with subsequent CRM. However, in more recent studies, 
while airway reactivity has been at least inconsistently associated 
with atopy in patients with repaired EA/TEF, increased bronchial 
hyper-reactivity has not shown to be associated with GERD. 
Based on a number of case reports and a small series, there is 
compelling evidence that bronchiectasis in patients with repaired 
EA/TEF is typically due to massive, chronic aspiration. The lack 
of consistent evidence that aspiration leads to CRM in patients 
with repaired EA/TEF almost certainly reflects the variety of ways 
in which aspiration can be diagnosed, the retrospective nature of 
research to date, which may well underestimate the severity and 
chronicity of prior aspiration events, and the effects of previous 
treatment of aspiration, such as fundoplication. Ideally, prospec-
tive studies will be needed carefully documenting esophageal 
function and GERD, and subsequent CRM. This would likely be 
the most effective way of quantifying the extent to which aspira-
tion influences subsequent pulmonary morbidity in this popula-
tion. Research is also required to determine the best methods of 
diagnosing aspiration, assessing the effects of aspiration on the 
lower airway microbiome, and assessing whether altered gastro-
intestinal mucosal immunity affects atopy in these patients. Given 
the strong association of aspiration with cryptogenic organizing 
pneumonia and evidence that restrictive pulmonary defects are 
relatively common in EA/TEF survivors, evaluation by CT and/
or biopsy is needed to determine whether at least some of the 
restrictive impairments seen in patients with repaired EA/TEF 
are due to cryptogenic organizing pneumonia.
Until additional data are available, there is a compelling 
need for long-term follow-up of these patients, ideally by mul-
tidisciplinary expert teams, both during childhood and during 
adulthood (4, 66). Respiratory follow-up should include serial 
PFTs including spirometry, measurement of lung volumes, and, 
possibly, evaluation of bronchodilator responsiveness (67, 68). 
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Chest radiography may be useful (59), and exercise testing and 
methacholine challenge should be considered when clinically 
indicated. If bronchiectasis is suspected, it is best diagnosed 
by CT of the chest. When bronchiectasis is confirmed, urgent 
evaluation of potential causes of aspiration should be carried out. 
Based on the evidence currently available, patients with repaired 
EA/TEF who have CRM should be evaluated for clinically signifi-
cant tracheomalacia, as well as for aspiration due to swallowing 
dysfunction, GERD, and/or a recurrent or persistent TEF.
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